Infections of implantable cardiac rhythm devices: Predisposing factors and outcome

Acta Cardiologica

Volumn 67, Issue 3, 2012, Pages 303-310

  Ipek, Esra Gucuk ^a   Guray, Umit ^a   Demirkan, Burcu ^a   Guray, Yesim ^a   Aksu, Tolga ^a  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

Author keywords

Device related endocarditis; Implantable cardiac rhythm devices; Pacemaker infections

Indexed keywords

ANTIBIOTIC AGENT;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANEMIA; ANTIBIOTIC THERAPY; ARTIFICIAL HEART PACEMAKER; BACTERIAL ENDOCARDITIS; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CLINICAL ARTICLE; COMORBIDITY; DEFIBRILLATOR; DEVICE INFECTION; DEVICE REMOVAL; DIABETES MELLITUS; EMBOLISM; FEMALE; HEART FAILURE; HEART RHYTHM; HEMATOMA; HOSPITALIZATION; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; IMPLANTABLE CARDIAC RHYTHM DEVICE INFECTION; INFECTION RATE; INOTROPISM; LENGTH OF STAY; MALE; MYCOSIS; RETROSPECTIVE STUDY; REVIEW; SEPTIC EMBOLUS; STAPHYLOCOCCUS AUREUS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TRICUSPID VALVE STENOSIS;

CHI-SQUARE DISTRIBUTION; COMORBIDITY; DEFIBRILLATORS, IMPLANTABLE; DEVICE REMOVAL; ECHOCARDIOGRAPHY; FEMALE; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; TURKEY;

EID: 84863955026     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.1080/ac.67.3.2160719     Document Type: Review

References (30)

1. Goldberger Z, Lampert R. Implantable cardioverter-defibrillators: expanding indications and technologies. JAMA 2006; 295: 809-818.
2. Karchmer AW, Longworth DL. Infections of intracardiac devices. Infect Dis Clin North Am 2002; 16: 477-505.
3. Greenspon AJ, Patel JD, Lau E, Ochoa JA, Frisch DR, Ho RT, Pavri BB, Kurtz SM. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol 2011; 58: 1001-1006.
4. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, Stoner S, Baddour LM. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. JACC 2007; 49: 1851-1859.
5. Kervan U, Altintas G, Ozen A, Durukan M, Guray U, Ozatik MA. Implantable cardioverter defibrillator lead endocarditis causing diffuse right atrial abscess and pulmonary artery embolism. Pacing Clin Electrophysiol 2011; 34: e115-e117.
6. Uslan DZ, Sohail MR, St Sauver JL, Friedman PA, Hayes DL, Stoner SM, Wilson MR, Steckelberg JM, Baddour LM. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med 2007; 167: 669-675.
7. Ferguson TB Jr, Ferguson CL, Crites K, Crimmins-Reda P. The additional hospital costs generated in the management of complications of pacemaker and defibrillator implantations. J Thorac Cardiovasc Surg 1996; 111: 742-751.
8. Voigt A, Shalaby A, Saba S. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights. Pacing Clin Electrophysiol 2010; 33: 414-419.
9. Conklin EF, Giannelli S Jr, Nealon TF Jr. Four hundred consecutive patients with permanent transvenous pacemakers. J Thorac Cardiovasc Surg 1975; 69: 1-7.
10. Bluhm G. Pacemaker infections. A clinical study with special reference to prophylactic use of some isoxazolyl penicillins. Acta Med Scand Suppl 1985; 699: 1-62.
11. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, Stoner SM, Baddour LM. Risk factor analysis of permanent pacemaker infection. Clin Infect Dis 2007; 45: 166-173.
12. Bloom H, Heeke B, Leon A, Mera F, Delurgio D, Beshai J, Langberg J. Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing Clin Electrophysiol 2006; 29: 142-155.
13. Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N, Rey JL, Lande G, Lazarus A, Victor J, Barnay C, Grandbastien B, Kacet S; PEOPLE Study Group. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation 2007; 116: 1349-1355.
14. Baman TS, Gupta SK, Valle JA, Yamada E. Risk factors for mortality in patients with cardiac device-related infection. Circ Arrhythm Electrophysiol 2009; 2: 129-134.
15. Baddour LM, Bettmann MA, Bolger AF, Epstein AE, Ferrieri P, Gerber MA, Gewitz MH, Jacobs AK, Levison ME, Newburger JW, Pallash TJ, Wilson WR, Baltimore RS, Falace DA, Shulman ST, Tani LY, Taubert KA. Nonvalvular cardiovascular device-related infections. Circulation 2003; 108: 2015-2031.
16. Arber N, Pras E, Copperman Y, Schapiro JM, Meiner V, Lossos IS, Militanu A, Hassin D, Shai A et al. Pacemaker endocarditis: report of 44 cases and review of the literature. Medicine (Baltimore) 1994; 73: 299-305.
17. Victor F, De Place C, Camus C, Le Breton H, Leclerc C, Pavin D, Mabo P, Daubert C. Pacemaker lead infection: echocardiographic features, management and outcome. Heart 1999; 81: 82-87.
18. Grammes JA, Schulze CM, Al-Bataineh M, Yesenosky GA, Saari CS, Vrabel MJ, Horrow J, Chowdhury M, Fontaine JM, Kutalek S P. Percutaneous pacemaker and implantable cardioverter-defibrillator lead extraction in 100 patients with intracardiac vegetations defined by transesophageal echocardiogram. J Am Coll Cardiol 2010; 55: 886-894.
19. Sohail MR, Uslan DZ, Khan AK, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, Jenkins SM, Baddour LM. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clin Proc 2008; 83: 46-53.
20. Massoure PL, Reuter S, Lafitte S, Laborderie J, Bordachard P, Clementy J, Roudaut R. Pacemaker endocarditis: clinical features and management of 60 consecutive cases. Pacing Clin Electrophysiol 2007; 30: 12-19.
21. Chua JD, Wilkoff BL, Lee I, Juratli N Longworth DL, Gordon SM. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 2000; 133: 604-608.
22. Margey R, McCann H, Blake G, Keelan E, Galvin J, Lynch M, Mahon N, Sugrue D, O'Neill J. Contemporary management of and outcomes from cardiac device related infections. Europace 2010; 12: 64-70.
23. Del Rio A, Anguera I, Miro JM, Mont L, Fowler VG Jr, Azqueta M, Mestres CA: Surgical treatment of pacemaker and defibrillator lead endocarditis: the impact of electrode lead extraction on outcome. Chest 2003; 124: 1451-1459.
24. Camus C, Leport C, Raffi F, Michelet C, Cartier F, Vilde JL. Sustained bacteremia in 26 patients with a permanent endocardial pacemaker: assessment of wire removal. Clin Infect Dis 1993; 17: 46-55.
25. Wilkoff BL, Love CJ, Byrd CL, Bongiorni MG, Carrillo RG, Crossley GH 3rd, Ebstein LM, Friedman RA, Kennenrgren CE, Mitkowski P, Schaerf RH, Wazni OM; Heart Rhythm Society; American Heart Association. Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). Heart Rhythm 2009; 6: 1085-1104.
26. Ruttmann E, Hangler HB, Kilo J, Höfr D, Müller LC, Hintringer F, Müller S, Laufer G, Antretter H. Transvenous pacemaker lead removal is safe and effective even in large vegetations: an analysis of 53 cases of pacemaker lead endocarditis. Pacing Clin Electrophysiol 2006; 29: 231-236.
27. Meier-Ewert HK, Gray ME, John RM. Endocardial pacemaker or defibrillator leads with infected vegetations: a single-center experience and consequences of transvenous extraction. Am Heart J 2003; 146: 339-344.
28. Aksu T, Durukan M, Guray U, Colak A. Extraction of a large vegetation and ICD lead using the Evolution Mechanical Dilator Sheath. Turk Kardiyol Dern Ars 2011; 39: 403-406 [in Turkish].
29. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med 2004; 350: 1422-1429.
30. Post JJ, Alexopoulos C, Fewtrell C, Giles R, Jones PD. Outcome after complete percutaneous removal of infected pacemaker systems and implantable cardiac defibrillators. Intern Med J 2006; 36: 790-792.